… to investigate the safety of hypoglycaemic agents in COVID-19 patients with diabetes [13]. …
analysing the effect of preadmission usage of metformin on the mortality of COVID-19 by PSM, …

… preadmission use of antidiabetic medications on the in-hospital mortality of patients with
COVID-19 having type 2 diabetes… Metformin, GLP-1RA, and SGLT-2i were associated with lower …

… risk factors associated with COVID-19, and treatment options focusing on diabetes patients
and the use of metformin pre-admission … of the mortality of diabetes patients with COVID-19 (…

… 000 COVID-19 patients with diabetes, we show that metformin is associated with a significantly
lower risk of all-cause and in-hospital mortality, … effects, preadmission metformin use was …

… Metformin exerts anti-inflammatory and immunosuppressive effects. We addressed the …
of prior metformin use on prognosis in patients with type 2 diabetes hospitalised for COVID-19. …

… could reduce the risks of influenza and complications [19]. Therefore, we … metformin use
before COVID-19 vaccination affects risk of COVID-19 incidence, medical utilization and mortality…

… metformin and insulin in both pre-admission and in-hospital usage in COVID-19 patients
with pre-existed type 2 diabetes… risk of mortality in confirmed COVID-19 cases with diabetes …

… among patients with COVID-19; however, the results are still inconclusive. This study …
association between metformin and the risk of mortality among diabetes patients with COVID-19. …

… Impact of comorbid diabetes on the risk of mortality from Covid-19. Studies reporting morality
… The risk of Covid-19 mortality in people with type 1 diabetes has been higher than with type …

… levels of IL-6 in diabetic patients with COVID-19 taking metformin compared to those who
did not … Association of preadmission metformin use and mortality in patients with sepsis and …